fotemustine has been researched along with Benign Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aquino, A; Bonmassar, E; De Rossi, A; De Vecchis, L; Laudisi, A; Leti, M; Marchesi, F; Rossi, L; Sini, V; Toppo, L; Torino, F; Tortorelli, G; Turriziani, M | 1 |
| Ardiet, C; Lind, MJ | 1 |
| Fety, R; Iliadis, A; Launay-Iliadis, MC; Lokiec, F; Lucas, C; Milano, G; Tranchand, B | 1 |
| Cour, V; Langenbahn, H | 1 |
| Baumelou, B; Bizzari, JP; Bourbouze, R; Deray, G; Jacobs, C; Jacquiaud, C; Jacquillat, C; Jaudon, MC; Khayat, D; Musset, L | 1 |
| Beerblock, K; Bizzari, JP; Deloffre, P; Lokiec, F; Lucas, C | 1 |
| Banzet, P; Bizzari, JP; Jacquillat, C; Khayat, D; Lokiec, F; Meeus, L; Rouesse, J; Sellami, M; Weil, M | 1 |
3 review(s) available for fotemustine and Benign Neoplasms
| Article | Year |
|---|---|
Focus on Fotemustine.
Topics: Animals; Antineoplastic Agents; DNA Repair; Drug Resistance, Neoplasm; Humans; Models, Animal; Neoplasms; Nitrosourea Compounds; Organophosphorus Compounds | 2006 |
Pharmacokinetics of alkylating agents.
Topics: Alkylating Agents; Carmustine; Chlorambucil; Cyclophosphamide; Humans; Ifosfamide; Lomustine; Melphalan; Neoplasms; Nitrosourea Compounds; Organophosphorus Compounds; Thiotepa | 1993 |
[Fotemustine, a new nitrosourea derivative. Current status of development].
Topics: Antineoplastic Agents; Drug Evaluation; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Neoplasms; Nitrosourea Compounds; Organophosphorus Compounds | 1990 |
1 trial(s) available for fotemustine and Benign Neoplasms
| Article | Year |
|---|---|
Renal effects of S10036 in man.
Topics: Acetylglucosaminidase; Antineoplastic Agents; beta 2-Microglobulin; Glomerular Filtration Rate; Hematocrit; Hemodynamics; Humans; Kidney; Kidney Tubules; Neoplasms; Nitrosourea Compounds; Organophosphorus Compounds; Renal Circulation | 1990 |
3 other study(ies) available for fotemustine and Benign Neoplasms
| Article | Year |
|---|---|
Pharmacokinetics and pharmacodynamics of nitrosourea fotemustine: a French cancer centre multicentric study.
Topics: Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Nitrosourea Compounds; Organophosphorus Compounds; Prospective Studies; Time Factors | 1996 |
[Study of the clinical pharmacokinetics of fotemustine in various tumor indications].
Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Male; Melanoma; Metabolic Clearance Rate; Middle Aged; Neoplasm Metastasis; Neoplasms; Nitrosourea Compounds; Organophosphorus Compounds | 1989 |
Phase I clinical study of the new amino acid-linked nitrosourea, S 10036, administered on a weekly schedule.
Topics: Adult; Antineoplastic Agents; Digestive System; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Nitrosourea Compounds; Organophosphorus Compounds; Thrombocytopenia | 1987 |